Complex Regional Pain Syndrome Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-01-16　·　152 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 109.76 Mn
2033 年預估規模: USD 138.56 Mn
年複合成長率 CAGR: 2.6%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-01-16頁數 152報告編號 CMI4988

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Complex Regional Pain Syndrome Market, By Disease Type (CRPS I, CRPS II, and CRPS-NOS), By Drug Type (T-121, NTRX-07, Neridronic Acid, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

The Complex Regional Pain Syndrome Market is estimated to be valued at USD 109.76 Mn in 2026 and is expected to reach USD 138.56 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 2.6% from 2026 to 2033. The Complex Regional Pain Syndrome (CRPS) market is attracting growing attention as chronic pain disorders become more prevalent and healthcare professionals and patients become more aware of the condition. CRPS is a rare but debilitating disorder that causes persistent, severe pain, often after an injury or surgery, significantly affecting patients’ quality of life. Patients and healthcare providers are driving demand for effective treatments, including pharmacological therapies, nerve blocks, physical rehabilitation, and innovative neuromodulation techniques, which in turn fuels research and development in this field. Advances in diagnostic tools and early intervention strategies are also helping clinicians improve patient outcomes and expand treatment adoption. Pharmaceutical companies, research institutions, and healthcare providers are actively developing novel therapies to reduce pain and enhance functionality. Increased investment in pain management and supportive care solutions, along with rising patient awareness and access to specialized care, is further boosting growth in the CRPS market. Market Dynamics The Complex Regional Pain Syndrome (CRPS) market grows as chronic pain conditions become more prevalent and the demand for effective treatments rises. CRPS, a complex neurological disorder, usually develops after injuries, surgeries, or trauma, causing severe, persistent pain that limits patients’ mobility and quality of life. Healthcare professionals and patients are increasingly recognizing the importance of early diagnosis and intervention, which accelerates the adoption of available therapies. Clinicians are expanding the use of pharmacological treatments, nerve blocks, physical therapy, and innovative neuromodulation techniques to provide comprehensive pain management and improve functional outcomes. Technological advancements and ongoing research are transforming the market landscape. Improved diagnostic tools, including advanced imaging and pain assessment methods, allow clinicians to detect CRPS earlier and target treatments more effectively. At the same time, the development of minimally invasive procedures and novel drug therapies is enhancing treatment outcomes and patient adherence. Pharmaceutical companies, academic institutions, and healthcare providers are collaborating to drive innovation, creating a diverse range of therapies that address pain, inflammation, and nerve dysfunction associated with CRPS. Investments in pain management infrastructure and supportive care services further support market growth. Specialized pain clinics, rehabilitation centers, and telemedicine platforms are expanding patient access to treatment. Meanwhile, patient advocacy initiatives and awareness programs educate individuals on symptom recognition and therapy options. Policy support and healthcare programs focused on chronic pain management are strengthening the market, promoting adoption, and encouraging ongoing innovation in CRPS treatment solutions. Key Features of the Study • This report provides in-depth analysis of the Complex Regional Pain Syndrome Market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the Complex Regional Pain Syndrome Market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Boston Scientific Corporation, GlaxoSmithKline plc., Johnson & Johnson, Viatris, Sanofi S.A, and Medtronic Plc. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The Complex Regional Pain Syndrome Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Complex Regional Pain Syndrome Market Market Segmentation • By Disease Type o CRPS I o CRPS II o CRPS - NOS • By Drug Type o T-121 o NTRX-07 o Neridronic Acid o Others • By Distribution Channel o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies o Others • By Regional Insights o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Boston Scientific Corporation o GlaxoSmithKline plc. o Johnson & Johnson o Viatris o Sanofi S.A o Medtronic Plc.

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Disease Type  Market Snippet, By Drug Type  Market Snippet, By Distribution Channel  Market Snippet, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  PEST Analysis  PORTER’s Five Forces Analysis  Market Opportunities  Regulatory Scenario  Key Developments  Industry Trend 4. Global Complex Regional Pain Syndrome Market, By Disease Type, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o CRPS I  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o CRPS II  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o CRPS-NOS  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends 5. Global Complex Regional Pain Syndrome Market, By Drug Type, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o T-121  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o NTRX-07  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Neridronic Acid  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Others  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 6. Global Complex Regional Pain Syndrome Market, By Distribution Channel, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Hospital Pharmacies  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Retail Pharmacies  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Online Pharmacies  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Others  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 7. Global Complex Regional Pain Syndrome Market, By Region, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, For Region, 2021 - 2033 o North America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o U.S. o Canada o Latin America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033  Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)  Market Size and Forecast, By Country, 2026- 2033, (USD Mn) o South Africa o North Africa o Central Africa 8. Competitive Landscape o Heat Map Analysis o Market Share Analysis (3x3 Matrix) o Company Profiles  Boston Scientific Corporation o Company Overview o Product Type Portfolio o Recent Developments/Updates  GlaxoSmithKline plc. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Johnson & Johnson o Company Overview o Product Type Portfolio o Recent Developments/Updates  Viatris o Company Overview o Product Type Portfolio o Recent Developments/Updates  Sanofi S.A o Company Overview o Product Type Portfolio o Recent Developments/Updates  Medtronic Plc. o Company Overview o Product Type Portfolio o Recent Developments/Updates 9. Analyst Recommendation o Wheel of Fortune o Analyst View o Coherent Opportunity Map 10. Section o References o Research Methodology o About Us and Sales Contact

提及公司

Boston Scientific CorporationGlaxoSmithKline plc.Johnson & JohnsonViatrisSanofi S.AMedtronic Plc.

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們